Purchases and Sales Made in Q1 2024 in Theravance Biopharma, Inc. (TBPH)
This table provides information about the institutional ownership of Theravance Biopharma, Inc. (TBPH) during Q1 2024. The information is specifically focused on institutions that hold shares of Theravance Biopharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-236K- 88.44% |
$1.94M - $2.74M
|
30.9K
$296K
|
|
|
May 15, 2024
Q1 2024
|
Newtyn Management, LLC
New York, NY |
SELL
|
- |
-256K- 13.48% |
$2.1M - $2.97M
|
1.64M
$15.8M
|
|
|
May 15, 2024
Q1 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-338K- 90.95% |
$2.78M - $3.92M
|
33.6K
$322K
|
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-379K- 8.27% |
$3.12M - $4.4M
|
4.21M
$40.4M
|
|
|
May 10, 2024
Q1 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-803K- 23.03% |
$6.6M - $9.31M
|
2.69M
$25.8M
|
|
|
May 14, 2024
Q1 2024
|
Seth Klarman
Baupost Group LLC | Boston, Ma
|
SELL
|
- |
-825K- 11.12% |
$6.78M - $9.56M
|
6.59M
$63.2M
|